Flu News and Research

RSS

SARS-CoV-2 occurrence compared with other respiratory viruses in children with acute respiratory infections

The current study examined the incidence of COVID-19 in children with ARI relative to other respiratory viruses during the second and third waves.

22 Feb 2022

Climate change is sickening, literally!

A news study highlights the change in disease spread with climate change across the globe.

21 Feb 2022

Broad-spectrum antiviral activity of picolinic acid against SARS-CoV-2 and Influenza A virus

Researchers investigate the potential of picolinic acid (PA) as an anti-SARS-CoV-2 treatment option.

21 Feb 2022

Prime Minister sets out the Government's plans to live with and manage COVID

Vaccines will remain the first line of defense against Covid-19 as the Prime Minister sets out the Government's plans to live with and manage the virus.

21 Feb 2022

Pathogens in pneumonia-associated respiratory samples from Wuhan prior to SARS-CoV-2 emergence

An interesting paper in PLoS Pathogens describes the broad situation with respect to respiratory pathogens that cause acute respiratory infection (ARI) and pneumonia in the city.

21 Feb 2022

COVID-19 survivors more likely to suffer from mental health problems

As the COVID-19 pandemic stretches into its third year, countless people have experienced varying degrees of uncertainty, isolation and mental health challenges.

17 Feb 2022

2022 adult immunization schedule released by ACIP

The Advisory Committee on Immunization Practices (ACIP) has released its 2022 Recommended Adult Immunization Schedule that includes changes to the zoster, pneumococcal, and hepatitis B vaccines.

17 Feb 2022

Smartphone-based COVID-19 detection system

In this interview, we speak to Professor Michael Mahan about his latest research which aimed to bring low-cost, state-of-the-art diagnostics to resource-limited settings.

17 Feb 2022

Study suggests tea polyphenols may modulate COVID-19 via intestinal microbiota

A new study discusses the state of current knowledge about the potential use of tea polyphenols in the prevention and treatment of COVID-19.

16 Feb 2022

UK's fight against zoonotic diseases receives a £200 million boost

The UK's fight against zoonotic diseases, including avian flu and bovine tuberculosis received a major boost today (16 February) with the allocation of £200 million for a programme of investment into world leading research facilities.

15 Feb 2022

Study suggests that epigenetic memory in innate immune cells could be the key to explaining long COVID

A new study may provide a partial explanation for the long-term immunologic phenomena associated with COVID-19.

15 Feb 2022

Research highlights the need to include diverse populations in immunogenetic studies

Disease and health are the result of a complex interaction between humans and their pathogens. Genetic factors that partly determine host defenses sometimes differ significantly between people and populations.

14 Feb 2022

Antihistamines may offer hope for long COVID patients

Researchers offer hope that an inexpensive over-the-counter medication could improve long COVID symptoms for a large proportion of these patients.

14 Feb 2022

Study finds Pfizer-BioNTech COVID vaccine doesn't increase pregnancy risk

A new JAMA Network study describes the effects of maternal COVID-19 vaccination on pregnancy outcomes and infant health.

14 Feb 2022

Researchers identify autoantibody targets in COVID-19 patients

In a new study, researchers have been investigating auto-immune responses to natural human antigens in COVID-19 patients.

14 Feb 2022

90 minutes of exercise after vaccination may provide an extra immune boost

Researchers at Iowa State University found 90 minutes of mild- to moderate-intensity exercise directly after a flu or COVID-19 vaccine may provide an extra immune boost.

12 Feb 2022

Wearable devices can help monitor wellness during recovery from COVID-19

Researchers compare the resting heart changes in individuals with COVID-19 with individuals diagnosed with seasonal influenza.

9 Feb 2022

UTSA awarded $6.8 million grant to establish a Coccidioidomycosis Collaborative Research Center

Mycology and immunology researchers from The University of Texas at San Antonio have been selected to receive a five-year, $6.8 million grant from the National Institutes of Health to establish a San Antonio-based Coccidioidomycosis Collaborative Research Center (SA-CCRC) focused on developing therapeutics and vaccines against coccidioidomycosis.

8 Feb 2022

PCR data sheds light on the dynamics of interspecies pathogen-pathogen interactions

The new study uses PCR data on 17 different pathogens, collected from clinical samples as part of the Seattle Flu Study, a community-based surveillance study of respiratory viral infections.

8 Feb 2022

Missouri’s war on public health shows extent of national rift

Republican Missouri state Sen. Mike Moon believes that covid-19 vaccinations, especially among children, should cease until the long-term effects are known.

8 Feb 2022